IP Library › Granted Patent US 11,864,891
Granted Patent B2
US 11,864,891 · App. 17/394,690 · Granted Jan 9, 2024

Zwitterion surface modifications for continuous sensors

Inventors: Robert J. Boock (Carlsbad, CA); Chris W. Dring (Fremont, CA)
Assignee: DEXCOM, INC.
A61B5/14865A61B5/1486A61B5/14532A61B5/14546
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,864,891
App. No.
17/394,690
Granted
Jan 9, 2024
Kind
B2
Abstract

Devices are provided for measurement of an analyte concentration, e.g., glucose in a host. The device can include a sensor configured to generate a signal associated with a concentration of an analyte; and a sensing membrane located over the sensor. The sensing membrane comprises a diffusion resistance domain configured to control a flux of the analyte therethrough. The diffusion resistance domain comprises one or more zwitterionic compounds and a base polymer comprising both hydrophilic and hydrophobic regions.

Claims (34)

1. A device for measurement of a concentration of an analyte, the device comprising:

a sensor configured to generate a signal associated with the concentration of the analyte; and

a sensing membrane located over the sensor, the sensing membrane comprising:

a diffusion resistance domain configured to control a flux of the analyte therethrough, wherein the diffusion resistance domain comprises:

a base polymer comprising a polyurethane or a polyurethane copolymer comprising both hydrophilic and hydrophobic regions; and

one or more zwitterionic compounds, wherein the one or more zwitterionic compounds comprise a betaine compound or derivative thereof; and

a bioprotective domain located over the sensing membrane,

wherein the one or more zwitterionic compounds are blended with the base polymer or layered upon the base polymer.

2. The device of claim 1 , wherein an amount of the one or more zwitterionic compounds in the diffusion resistance domain is less than about 10% wt. of the diffusion resistance domain.

3. The device of claim 1 , wherein an amount of the one or more zwitterionic compounds in the diffusion resistance domain is less than about 5% wt. of the diffusion resistance domain.

4. The device of claim 1 , wherein the one or more zwitterionic compounds that comprise the betaine compound or derivative thereof comprise at least one compound selected from the group consisting of a carboxyl betaine compound, a sulfa betaine compound, a phosphor betaine compound, and derivatives thereof.

5. The device of claim 1 , wherein the one or more zwitterionic compounds that comprise the betaine compound or derivative thereof comprise at least one compound selected from the group consisting of cocamidopropyl betaine, oleamidopropyl betaine, octyl sulfobetaine, caprylyl sulfobetaine, lauryl sulfobetaine, myristyl sulfobetaine, palmityl sulfobetaine, stearyl sulfobetaine, betaine(trimethylglycine), octyl betaine, phosphatidylcholine, glycine betaine, poly(carboxybetaine), poly(sulfobetaine), and derivatives thereof.

6. The device of claim 1 , wherein the one or more zwitterionic compounds that comprise the betaine compound or derivative thereof comprise at least one compound selected from the group consisting of poly(carboxybetaine), poly(sulfobetaine), and derivatives thereof.

7. The device of claim 1 , wherein the sensing membrane further comprises an enzyme domain comprising an enzyme selected from the group consisting of glucose oxidase, glucose dehydrogenase, galactose oxidase, cholesterol oxidase, amino acid oxidase, alcohol oxidase, lactate oxidase, and uricase.

8. The device of claim 7 , wherein the enzyme is glucose oxidase.

9. The device of claim 1 , wherein the polyurethane copolymer comprises a polyether-urethane-urea copolymer, a polycarbonate-urethane copolymer, a polyether-urethane copolymer, a silicone-polyether-urethane copolymer, a silicone-polycarbonate-urethane copolymer, a polyester-urethane copolymer, or a mixture thereof.

10. The device of claim 9 , wherein the polyurethane copolymer comprises the polycarbonate-urethane copolymer.

11. The device of claim 1 , wherein the analyte comprises glucose.

12. The device of claim 1 , wherein the bioprotective domain comprises a polymer containing fluorine.

13. The device of claim 12 , wherein the polymer includes from about 1% to about 25% fluorine by weight.

14. A device for measurement of a concentration of an analyte, the device comprising:

a sensor configured to generate a signal associated with the concentration of the analyte; and

a sensing membrane located over the sensor, the sensing membrane comprising:

a diffusion resistance domain configured to control a flux of the analyte therethrough, wherein the diffusion resistance domain comprises:

a base polymer comprising a polyurethane or a polyurethane copolymer comprising both hydrophilic and hydrophobic regions; and

one or more zwitterionic compounds, wherein the one or more zwitterionic compounds comprise a betaine compound or derivative thereof; and

a bioprotective domain located over the sensing membrane and including the one or more zwitterionic compounds, precursors, or derivatives thereof,

wherein the one or more zwitterionic compounds are blended with the base polymer or layered upon the base polymer.

15. The device of claim 14 , wherein the polyurethane copolymer comprises a polyether-urethane-urea copolymer, a polycarbonate-urethane copolymer, a polyether-urethane copolymer, a silicone-polyether-urethane copolymer, a silicone-polycarbonate-urethane copolymer, a polyester-urethane copolymer, or a mixture thereof.

16. The device of claim 14 , wherein the one or more zwitterionic compounds that comprise the betaine compound or derivative thereof comprise at least one compound selected from the group consisting of cocamidopropyl betaine, oleamidopropyl betaine, octyl sulfobetaine, caprylyl sulfobetaine, lauryl sulfobetaine, myristyl sulfobetaine, palmityl sulfobetaine, stearyl sulfobetaine, betaine(trimethylglycine), octyl betaine, phosphatidylcholine, glycine betaine, poly(carboxybetaine), poly(sulfobetaine), and derivatives thereof.

17. The device of claim 14 , wherein the one or more zwitterionic compounds that comprise the betaine compound or derivative thereof comprise at least one compound selected from the group consisting of a carboxyl betaine compound, a sulfa betaine compound, a phosphor betaine compound, and derivatives thereof.

18. The device of claim 14 , wherein the sensing membrane further comprises an enzyme domain comprising an enzyme selected from the group consisting of glucose oxidase, glucose dehydrogenase, galactose oxidase, cholesterol oxidase, amino acid oxidase, alcohol oxidase, lactate oxidase, and uricase.

19. The device of claim 14 , wherein the analyte comprises glucose.

20. The device of claim 14 , wherein the one or more zwitterionic compounds, precursors, or derivatives thereof of the bioprotective domain comprises from 0.1 wt. % to about 5% wt. % of the bioprotective domain.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2023
From: BOOCK, ROBERT J.; DRING, CHRIS W.
To: DEXCOM, INC.
Reel/Frame 064532/0560 →
Continuity (7)
Continuation 16721675 · Dec 19, 2019
Continuation 15946617 · Apr 5, 2018
Continuation 15458817 · Mar 14, 2017
Continuation 14543644 · Nov 17, 2014
Continuation 13779607 · Feb 27, 2013
Provisional Application 61707652 · Sep 28, 2012
Related Publication 20210361205A1 · Nov 25, 2021
Cited By (1)
US 12,727,793